Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Losartan in Bicuspid Aortic Valve Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adults \>age 18 years and \< 65 years old~* Able to give informed consent~* Presence of a bicuspid aortic valve (functional or true bicommisural)and ascending aorta or sinus of Valsalva \>4.0cm~* No contraindications to treatment with Losartan, an Angiotensin II receptor blocker~* Able to safely participate in a 4 week drug washout period if currently taking an angiotensin II receptor blocker or ACE inhibitor.~Exclusion Criteria:~* Unable to safely take losartan due to one or more of the following:~  * Hypersensitivity to losartan or other angiotensin receptor blockers~ * Pregnancy~ * Nursing mothers~ * History of angioedema~ * Hypotension - chronically volume depleted patients~ * Hepatic or renal impairment (Cr\>1.5mg/dL)~ * Hyperkalemia (K+\>4.8)~ * Renal artery stenosis~ * Severe congestive heart failure (class III-IV)~ * Currently taking potassium supplements or salt substitutes containing potassium~ * Currently taking lithium~* Prior surgical intervention to aorta or aortic valve~* Unable or unwilling to give informed consent and follow up with study activities~* Currently taking an angiotensin receptor blocker or ACE inhibitor specifically for hypertension and are therefore unable to or are unwilling to participate in a 4 week drug washout period.~* Females of child bearing who are unwilling to practice adequate birth control throughout the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Losartan (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).